218 related articles for article (PubMed ID: 7109173)
21. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis.
Kingwatanakul P; Warady BA
Adv Perit Dial; 1997; 13():281-4. PubMed ID: 9360700
[TBL] [Abstract][Full Text] [Related]
22. Carrier-status for nasal staphylococci does not predict infections in CAPD patients.
Lubrich-Birkner I; Schollmeyer P; Böhler J
Adv Perit Dial; 1994; 10():154-7. PubMed ID: 7999816
[TBL] [Abstract][Full Text] [Related]
23. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
[TBL] [Abstract][Full Text] [Related]
24. Nasal carriage of Staphylococcus aureus in families of children on peritoneal dialysis. European Pediatric Peritoneal Dialysis Study Group (EPPS).
Oh J; von Baum H; Klaus G; Schaefer F
Adv Perit Dial; 2000; 16():324-7. PubMed ID: 11045321
[TBL] [Abstract][Full Text] [Related]
25. "Pulse" nasal mupirocin maintenance regimen in patients undergoing continuous ambulatory peritoneal dialysis.
Mylotte JM; Kahler L; Jackson E
Infect Control Hosp Epidemiol; 1999 Nov; 20(11):741-5. PubMed ID: 10580624
[TBL] [Abstract][Full Text] [Related]
26. Structural defects in chronic peritoneal dialysis catheters contributing to peritonitis.
Roxe DM; Santhanam S
Nephron; 1983; 34(4):267-8. PubMed ID: 6877463
[TBL] [Abstract][Full Text] [Related]
27. Prevention of staphylococcal peritonitis in CAPD patients combining ablution and mupirocin.
Al-Hwiesh AK; Abdul Rahman IS
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):737-45. PubMed ID: 18711288
[TBL] [Abstract][Full Text] [Related]
28. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
[TBL] [Abstract][Full Text] [Related]
29. Staph aureus peritonitis in patients on continuous ambulatory peritoneal dialysis.
Kim D; Tapson J; Wu G; Khanna R; Vas SI; Oreopoulos DG
Trans Am Soc Artif Intern Organs; 1984; 30():494-7. PubMed ID: 6533929
[No Abstract] [Full Text] [Related]
30. Staphylococcus aureus infections during peritoneal dialysis.
Coles GA
J Chemother; 1995 Jul; 7 Suppl 3():67-70. PubMed ID: 8609540
[TBL] [Abstract][Full Text] [Related]
31. Peritonitis in children undergoing dialysis. 10 years experience.
Levy M; Balfe JW; Geary DF; Fryer-Keene SP; Bannatyne RM
Child Nephrol Urol; 1988-1989; 9(5):253-8. PubMed ID: 3271590
[TBL] [Abstract][Full Text] [Related]
32. A prospective study of peritoneal dialysis-related infections in CAPD patients with diabetes mellitus.
Lye WC; Leong SO; van der Straaten JC; Lee EJ
Adv Perit Dial; 1993; 9():195-7. PubMed ID: 8105922
[TBL] [Abstract][Full Text] [Related]
33. Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Pignatari A; Pfaller M; Hollis R; Sesso R; Leme I; Herwaldt L
J Clin Microbiol; 1990 Sep; 28(9):1898-902. PubMed ID: 2172293
[TBL] [Abstract][Full Text] [Related]
34. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
[TBL] [Abstract][Full Text] [Related]
35. Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD.
Lye WC; Leong SO; Lee EJ
Kidney Int; 1993 Jun; 43(6):1357-62. PubMed ID: 8315950
[TBL] [Abstract][Full Text] [Related]
36. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.
Yu VL; Goetz A; Wagener M; Smith PB; Rihs JD; Hanchett J; Zuravleff JJ
N Engl J Med; 1986 Jul; 315(2):91-6. PubMed ID: 3523240
[TBL] [Abstract][Full Text] [Related]
37. Outcome and complications in peritoneal dialysis patients: a five-year single center experience.
Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H
Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621
[TBL] [Abstract][Full Text] [Related]
38. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.
Zimmerman SW; Ahrens E; Johnson CA; Craig W; Leggett J; O'Brien M; Oxton L; Roecker EB; Engeseth S
Am J Kidney Dis; 1991 Aug; 18(2):225-31. PubMed ID: 1867179
[TBL] [Abstract][Full Text] [Related]
39. Methicillin-resistant staphylococcal infections in an outpatient peritoneal dialysis program.
Holley JL; Bernardini J; Johnston JR; Piraino B
Am J Kidney Dis; 1990 Aug; 16(2):142-6. PubMed ID: 2382651
[TBL] [Abstract][Full Text] [Related]
40. Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients.
Herwaldt LA
J Hosp Infect; 1998 Sep; 40 Suppl B():S13-23. PubMed ID: 9777529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
